Guardant Health Stock In The News
| GH Stock | USD 18.10 0.76 4.38% |
The overall news coverage of Guardant Health from major news outlets shows bearish sentiment on 15 news articles, blog posts, and TV commentaries analyzed in the last few months. Our overall analysis of Guardant Health's news coverage and content from conventional and social sources shows investors' bearish mood towards Guardant Health. The specific impact of Guardant Health news on its stock price will depend on a range of factors, including the nature and significance of the news report and investors' perceptions of Guardant Health's overall financial health and prospects. It also depends on the type and quality of a news publisher.
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using Guardant Health headlines in addition to utilizing other, more conventional financial analysis modules. Check out Guardant Health Backtesting and Guardant Health Hype Analysis. For more detail on how to invest in Guardant Stock please use our How to Invest in Guardant Health guide.
Guardant |
Guardant Health Today Top News and Investor Outlook
Guardant Health Past News Timeline
Popular news outlets such as MarketWatch, Bloomberg, or Reuters provide Guardant and other traded companies coverage. We help investors stay connected with Guardant headlines for the 24th of April to make an informed investment decision based on correlating the impacts of news items on Guardant Stock performance. Please note that trading solely based on the Guardant Health hype is not for everyone as timely availability and quick action are needed to avoid losses.Guardant Health stock price changes are notoriously difficult to predict based exclusively on its news coverage or social hype. Still, the Guardant earnings-per-share ratio is a good starting point for gauging a company's future prospects. If a firm's EPS rises and meets or even beats consensus forecasts, its shares stand to increase. However, some very sophisticated investors can spot management manipulation of EPS through actions such as buybacks.
Far too much social signal, news, headlines, and media speculation about Guardant Health that are available to investors today. That information is available publicly through Guardant media outlets and privately through word of mouth or via Guardant internal channels. However, regardless of the origin, that massive amount of Guardant data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Guardant Health news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Guardant Health relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Guardant Health's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Guardant Health alpha.
Guardant Largest EPS Surprises
Earnings surprises can significantly impact Guardant Health's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2020-02-24 | 2019-12-31 | -0.31 | -0.27 | 0.04 | 12 | ||
2019-03-12 | 2018-12-31 | -0.35 | -0.3 | 0.05 | 14 | ||
2019-05-09 | 2019-03-31 | -0.37 | -0.3 | 0.07 | 18 | ||
2020-05-07 | 2020-03-31 | -0.39 | -0.29 | 0.1 | 25 | ||
2021-08-05 | 2021-06-30 | -0.85 | -0.96 | -0.11 | 12 | ||
2022-11-03 | 2022-09-30 | -1.26 | -1.41 | -0.15 | 11 |
Guardant Health Stock Latest Headlines
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using conventional financial analysis. Below is the latest headlines and news related to Guardant Health Stock. The global stock market is bearish. About 60% of major world exchanges and indexes are down. See today's market update for more information.
22nd of April 2024
FDA Advisory Panel Review of Guardant Healths Shield Blood Test to Screen for Colorectal C... at businesswire.com
16th of April 2024
Guardant Health Sets New 12-Month Low Following Analyst Downgrade - MarketBeat at news.google.com
5th of April 2024
Guggenheim Reiterates Neutral Rating for Guardant Health - MarketBeat at news.google.com
3rd of April 2024
Guardant Health to Present Data Highlighting Application of Epigenomics to Advance Precisi... at investing.com
19th of March 2024
EDAN et GH Labs collaborent pour dvelopper des appareils ultrasons bass sur lIA at prnewswire.com
18th of March 2024
EDAN y GH Labs colabora para desarrollar dispositivos de ultrasonido habilitados para IA at prnewswire.com
14th of March 2024
Guardant Health Reaches New 12-Month Low at 18.18 - MarketBeat at news.google.com
29th of February 2024
Acquisition by Krognes Steve E. of 154 shares of Guardant Health subject to Rule 16b-3 at globenewswire.com
22nd of February 2024
Guardant Health Non-GAAP EPS of -0.64 beats by 0.11, revenue of 155.1M beats by 4.31M at seekingalpha.com
Guardant Health Investors Sentiment
The influence of Guardant Health's investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Guardant. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock market does not have solid backing from leading economists and market statisticians.
Investor biases related to Guardant Health's public news can be used to forecast risks associated with an investment in Guardant. The trend in average sentiment can be used to explain how an investor holding Guardant can time the market purely based on public headlines and social activities around Guardant Health. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Guardant Health's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Guardant Health's and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average Guardant Health's news discussions. The higher the estimated score, the more favorable is the investor's outlook on Guardant Health.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Guardant Health in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Guardant Health's short interest history, or implied volatility extrapolated from Guardant Health options trading.
Check out Guardant Health Backtesting and Guardant Health Hype Analysis. For more detail on how to invest in Guardant Stock please use our How to Invest in Guardant Health guide.Note that the Guardant Health information on this page should be used as a complementary analysis to other Guardant Health's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.
Complementary Tools for Guardant Stock analysis
When running Guardant Health's price analysis, check to measure Guardant Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Guardant Health is operating at the current time. Most of Guardant Health's value examination focuses on studying past and present price action to predict the probability of Guardant Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Guardant Health's price. Additionally, you may evaluate how the addition of Guardant Health to your portfolios can decrease your overall portfolio volatility.
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. |
Is Guardant Health's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Guardant Health. If investors know Guardant will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Guardant Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (4.28) | Revenue Per Share 5.036 | Quarterly Revenue Growth 0.222 | Return On Assets (0.18) | Return On Equity (4.38) |
The market value of Guardant Health is measured differently than its book value, which is the value of Guardant that is recorded on the company's balance sheet. Investors also form their own opinion of Guardant Health's value that differs from its market value or its book value, called intrinsic value, which is Guardant Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Guardant Health's market value can be influenced by many factors that don't directly affect Guardant Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Guardant Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if Guardant Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Guardant Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.